World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
132
Citations
76532
World Ranking
2290
National Ranking
1295

Markku Miettinen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Markku Miettinen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 514 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Markku Miettinen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Markku Miettinen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Markku Miettinen is affiliated with the National Cancer Institute in the United States and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans a variety of specialized subfields, including pulmonary and respiratory medicine, surgery, molecular biology, oncology, and pathology and forensic medicine.

The main areas of their work focus on sarcoma diagnosis and treatment, genetic factors in colorectal cancer, adrenal and paraganglionic tumors, neuroblastoma research and treatments, Helicobacter pylori-related gastroenterology studies, tumors and oncological cases, and advances in neuroendocrine tumor research.

Markku Miettinen has frequently collaborated with several coauthors, including Jerzy Lasota, Jeremy L. Davis, Lauren A. Gamble, Martha Quezado, and Theo Heller. Their publications regularly appear in journals such as the Journal of Thoracic Oncology, The American Journal of Surgical Pathology, Modern Pathology, Neuro-Oncology, and bioRxiv (Cold Spring Harbor Laboratory).

Selected recent papers authored or coauthored by Miettinen include:

  • Gastrointestinal stromal tumours, 2021, Nature Reviews Disease Primers

Other notable publications from the same period, though not authored by Miettinen but indicative of the research environment, include:

  • Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers, 2021, Journal of Thoracic Oncology
  • PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors, 2022, The American Journal of Surgical Pathology
  • Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study, 2023, The Lancet Oncology
  • Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors, 2022, Molecular Cancer Therapeutics

Best Publications

  • Diagnosis of gastrointestinal stromal tumors: A consensus approach.

    Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein

  • Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal stromal tumors: Pathology and prognosis at different sites

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

    Markku Miettinen;Leslie H Sobin;Jerzy Lasota

  • Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases

    Markku Miettinen;Janusz Kopczynski;Hala R. Makhlouf;Maarit Sarlomo-Rikala

  • Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

    Markku Miettinen;Wa'el El-Rifai;Wa'el El-Rifai;Leslie H L Sobin;Leslie H L Sobin;Jerzy Lasota;Jerzy Lasota

  • Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

    Markku Miettinen;Hala Makhlouf;Leslie H Sobin;Jerzy Lasota

  • Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).

    Markku Miettinen;Leslie H. Sobin;Maarit Sarlomo-Rikala

  • Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals.

    William L. Gerald;Hariatmi K. Miller;Hector Battifora;Markku Miettinen

  • Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas

    Jerzy Lasota;Marek Jasinski;Maarit Sarlomo-Rikala;Markku Miettinen

  • Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors.

    Andrew L. Folpe;Julie C. Fanburg-Smith;Markku Miettinen;Sharon W. Weiss

  • Gastrointestinal stromal tumors: radiologic features with pathologic correlation.

    Angela D Levy;Helen E Remotti;William M Thompson;Leslie H Sobin

  • Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.

    Markku Miettinen;James M. Monihan;Maarit Sarlomo-Rikala;Albert J. Kovatich

  • Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review

    Markku Miettinen;Mourad Majidi;Jerzy Lasota

  • KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.

    Markku Miettinen;Jerzy Lasota

  • Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

    Andrew L. Folpe;Julie C. Fanburg-Smith;Steven D. Billings;Michele Bisceglia

  • Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.

    Markku Miettinen;Maarit Sarlomo-Rikala;Leslie H. Sobin;Jerzy Lasota

  • Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

    Markku Miettinen;John F Fetsch;Leslie H Sobin;Jerzy Lasota

  • DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

    Markku Miettinen;Zeng-Feng Wang;Jerzy Lasota

Frequent Co-Authors

Jerzy Lasota
Jerzy Lasota National Institutes of Health
Leslie H. Sobin
Leslie H. Sobin National Cancer Institute
Sakari Knuutila
Sakari Knuutila University of Helsinki
Michal Michal
Michal Michal Charles University
Leif C. Andersson
Leif C. Andersson University of Helsinki
Wael El-Rifai
Wael El-Rifai University of Miami
Lester D. R. Thompson
Lester D. R. Thompson Kaiser Permanente
Lee J. Helman
Lee J. Helman Children's Hospital of Los Angeles
Paul S. Meltzer
Paul S. Meltzer National Institutes of Health
Theo Heller
Theo Heller National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t just mean pursuing a traditional MD. Many students consider alternative roles in healthcare, supported by flexible online education. For those aiming for advanced practice, options like the 1 year dnp program online offer an accelerated pathway to a Doctor of Nursing Practice, perfect for professionals eager to move forward quickly.

Some programs are designed to be more accessible for working nurses. The easiest dnp program reddit discussion highlights programs that balance rigor and flexibility, helping learners find options that align with their career goals and lifestyle needs.

Entry-level options are also available. Becoming a licensed practical nurse opens doors, and choosing an lpn program online can accelerate your entry into the workforce. Those interested in mental health can advance through the fastest psych np program, which prepares graduates for specialized nursing roles quickly.

Whether you’re starting out or looking to specialize, these online pathways provide flexible and efficient routes to diverse healthcare careers in the USA.

Best Scientists Citing Markku Miettinen

Trending Scientists

Recently Published Articles